GoKawiilStudy ties gut bacterium B. uniformis and an odd-chain fatty acid to reduced atherosclerosis in mice
Researchers compared gut microbiota from people with and without disease and found several bacterial genera, including Bacteroides uniformis, enriched in healthy individuals. In mouse experiments, oral dosing with B. uniformis colonized the gut, reduced aortic plaque buildup measured by Oil Red O staining, and affected metabolic markers such as glucose tolerance tests and liver mass compared with controls.
GoKawiil's interpretation of the reporting above, not reported fact.
The findings suggest a specific gut microbe and its metabolic byproduct, an odd-chain fatty acid, could influence cardiovascular disease progression, pointing toward a possible microbiome-based therapeutic avenue. Because this evidence comes primarily from mouse models and correlational human microbiome data, further research would be needed before suggesting clinical application in humans.
- Bacteroides uniformis was found enriched in healthy human gut microbiomes compared to disease cases.
- Oral administration of B. uniformis reduced atherosclerotic plaque in mouse aortas in controlled experiments.
- Metabolic indicators like glucose tolerance and liver mass also differed with B. uniformis treatment, suggesting broader physiological effects.
Source: nature.com — Yin, 2026-10-07
Published there as: “A gut microbial odd-chain fatty acid alleviates atherosclerosis in mice”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.